Independent Director Sumit Bose ceased to be a director of hdfc life insurance on July 18, 2026, following the completion of his tenure comprising two consecutive terms of five years each. The cessation took effect at the close of business hours. This transition impacts the company's board composition as it adheres to regulatory tenure limits for independent directors.

The Board of Directors, at its meeting held on July 15, 2026, placed on record its deep appreciation for the valuable contributions made by Mr Bose during his tenure as an Independent Director and expressed its sincere gratitude for his invaluable guidance and support to the company throughout his tenure. The company disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Details of Cessation

Three prominent global brokerages have maintained their bullish stance on HDFC Life Insurance , with Citi raising its target price to ₹990 even as weakness in the parent bank channel continues to weigh on near-term volumes. Improving traction in non-parent distribution channels and a favorable product mix are seen as key drivers supporting the company's growth trajectory. Macquarie and Bernstein have also retained their positive ratings, pointing to stable margins and attractive valuations as additional pillars of the investment case.

Brokerage Ratings and Target Prices

The following table summarizes the latest ratings and target prices from the three brokerages:

Citi: Non-Parent Channel Traction to Drive VNB Revival

Citi has maintained its Buy rating on HDFC Life Insurance while raising its target price to ₹990. The brokerage acknowledges that weak volumes from the parent bank channel remain a near-term headwind. However, it notes that improving traction in non-parent channels, combined with a favorable product mix, positions the company to revive Value of New Business (VNB) growth to the mid-to-high teens over the medium term.

Macquarie: Richer Product Mix Keeps Margins Stable

Macquarie has retained its Outperform rating with a target price of ₹860. The brokerage highlights that while growth was dragged by the parent bank channel, a richer product mix — led by protection and annuity products — helped keep margins stable. Macquarie also points to attractive valuations as a key support for the investment case.

Bernstein: Recovery in Parent Bank Sales Improves Outlook

Bernstein has maintained its Outperform rating with a target price of ₹810. Despite characterizing the recent quarter as weak, with soft bancassurance sales, Bernstein notes that recovery in parent bank sales and regained counter-share improve the overall outlook. The brokerage also highlights that management has prioritized growth while providing guidance for stable margins going forward.

Key Themes Across Brokerages

Across all three brokerage views, several common themes emerge:

• Parent bank channel weakness has been a shared concern impacting near-term growth
• Non-parent channel diversification is seen as a mitigating factor by Citi
• Protection and annuity product mix is credited by Macquarie for sustaining margin stability
• Attractive valuations are cited as a supportive factor for the stock
• Management guidance for stable margins alongside a growth focus is noted by Bernstein as a positive signal

The convergence of positive ratings from Citi, Macquarie, and Bernstein reflects a broadly constructive view on HDFC Life Insurance, with the company's product mix strategy and channel diversification efforts seen as central to navigating the current period of parent bank channel softness.